Controlled study comparing nomifensine and clomipramine in unipolar depression, using the probenecid technique

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Central dopamine turnover may be reduced in unipolar endogenous depression, especially with retardation.
• Motor inhibition is a key symptom in some depressive patients, potentially linked to dopaminergic dysfunction.

Purpose of the Study:

• To compare the efficacy of nomifensine and clomipramine in treating recurrent unipolar depression.
• To investigate the relationship between central dopamine turnover and treatment response in depression.

Main Methods:

• A double-blind, randomized controlled trial comparing nomifensine and clomipramine.
• Weekly biochemical assessments (cisternal liquor homovanillic acid) and clinical evaluations (Hamilton Depression Scale) over 4 weeks.

Main Results:

• Nomifensine selectively activated the central dopaminergic system.
• Patients responding to nomifensine had significantly lower baseline homovanillic acid levels.
• The 'retardation' factor on the Hamilton Depression Scale improved more with nomifensine than clomipramine.

Conclusions:

• Nomifensine demonstrates therapeutic potential for unipolar depression, particularly in patients with motor inhibition.
• Lower central dopamine turnover may predict a positive response to dopaminergic agents like nomifensine.